Gow Media launched a new platform and sister site to InnovationMap with a reception at The Grove on Nov. 5. Photo by Jacob Power

On a crisp Election Night evening, Houstonians motored to The Grove to mix and mingle at the exclusive launch party for the hottest new destination for car lovers, AutomotiveMap.

The newest site from Gow Media and the team behind CultureMap, InnovationMap, and SportsMap, AutomotiveMap will steer passionate readers to the latest car news and inside looks at the hottest rides, from an army of in-the-know experts.

The exclusive event featured a host of business leaders, social stars, and motoring enthusiasts. Gow Media CEO David Gow welcomed guests, explaining the "wild ride" growth of Gow Media's platforms and introducing the new site and founding editor, Eileen Falkenberg-Hull.

"What I love about Eileen is that she knows everything about about autos, she's a great writer, and she's savvy," Gow noted.

Falkenberg-Hull laid out the map for AutomotiveMap. "AutomotiveMap appeals to the average customer with the goal of informing their purchasing decisions," she explained. "It engages with enthusiasts and works to encourage enthusiasm among those discovering their passion. And it covers a wide variety of material from new cars to auto industry innovations to sexy cars and car culture."

While trading cool car stories, guests noshed on a feast provided by The Grove, including bacon-wrapped quail, fried truffle macaroni and cheese, tuna tartare tacos, avocado toast with lentils and radishes, and fried fish fritters. A smorgasbord in the form of a massive antipasto station with cured meats and cheeses greeted diners.

Attendees also snapped pics at the selfie booth and clamored around ESPN 97.5 hosts Fred Faour, A.J. Hoffman, and Glenn Davis as the teams broadcasted live from the event.

"I don't think people realize how many people have a passion for cars in this city," said avid car collector Alan Stein, whose collection ranges from a 1935 Chrysler AirFlow to new Ferraris. "A lot of it is under the radar. I think people love their cars, their collections, and so this will be interesting."

Seen in the crowd were NBA legend, Elvin Hayes; Nick Florescu; Elizabeth Stein; Lawson Gow; John and Leah Manlove; John and Mary Craddock; David Stevenson; Scott and Linda Burdine; Steven and Andi Berkman; Mark and Meredith Barineau; Audrey Gow; Natalie Harms; Chris Dvorachek; Justin Makris; and Neal Patel.

Revved-up enthusiasts can follow AutomotiveMap daily as well as on Facebook, Instagram, and Twitter.

"The launch party is just the beginning," said Falkenberg-Hull. "AutomotiveMap will evolve to be a true multimedia destination for everything automotive."

------

This article originally ran on CultureMap.

AutomotiveMap is the newest outlet from Gow Media. Courtesy graphic

Announcing AutomotiveMap: The new destination for auto enthusiasts has arrived

Calling all car fans

The automotive industry is now on the map. Gow Media, the large multi-platform media company with leading online destinations CultureMap, SportsMap, and InnovationMap, as well as sports radio properties ESPN 97.5 FM in Houston and SB Nation Radio, has announced the launch of its newest outlet, AutomotiveMap.

The new site will cover industry news from coast to coast, provide auto reviews, showcase innovation, and serve as a thoughtful guide to consumers.

"We are excited to add AutomotiveMap to our portfolio of media platforms," says David Gow, CEO of Gow Media. "We now have four content categories — culture, sports, innovation, and automotive — all under the 'map' brand identity. And we love that each of these categories taps into the passions of our audiences.

"Eileen Falkenberg-Hull will serve as inaugural editor of AutomotiveMap. She brings 10 years of digital publishing experience to her new position and has covered the automotive segment exclusively for five years, with regular bylines in Trucks.com, U.S. News & World Report, and American City Business Journals. She is a co-host of Let's Talk Wheels on SB Nation Radio.

In her new role, Falkenberg-Hull will report to Arden Ward, vice president of editorial for Gow Media statewide. "Eileen is an outstanding addition to our team," says Ward. "Her enthusiasm for the auto industry is unmatched, and, as editor, she blends her extensive knowledge with an approachable voice that connects to our readers."

"I am thrilled to become part of Gow Media," says Falkenberg-Hull. "I have been impressed with the creative energy, professionalism, and commitment to storytelling that the team has. AutomotiveMap will be both informative and highly engaging; it will educate consumers and delight enthusiasts."

AutomotiveMap is the latest addition to Gow Media's ever-growing portfolio. Since acquiring CultureMap in February of 2017, Gow has launched SportsMap; InnovationMap; and GiftingMap, an e-commerce site.

"Our other site launches are going very well — we are experiencing tremendous audience and revenue growth — enabling us to step out again with AutomotiveMap," says David Gow.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.